{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/313446364",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/975559344"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#313446364",
  "code": "3A51.3",
  "source": "http://id.who.int/icd/entity/313446364",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/313446364/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/2000854880",
        "http://id.who.int/icd/release/11/2024-01/mms/1496633964",
        "http://id.who.int/icd/release/11/2024-01/mms/1314118973",
        "http://id.who.int/icd/release/11/2024-01/mms/536467755",
        "http://id.who.int/icd/release/11/2024-01/mms/658360080"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Compound heterozygous sickling disorders without crisis"
  },
  "definition": {
    "@language": "en",
    "@value": "A disease caused by genetic inheritance of two heterozygous recessive alleles of the haemoglobin gene leading to abnormal formation of haemoglobin molecule. This disease is characterised by rigid, sickle shaped red blood cells. Confirmation is by identification of mutations through genetic testing."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Sickle cell Hb-C disease without crisis"
      },
      "foundationReference": "http://id.who.int/icd/entity/135961609"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Sickle cell thalassaemia without crisis"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    }
  ],
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1426960900"
  ],
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/1148519290"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Compound heterozygous sickling disorders without crisis"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "double heterozygous sickling disorder"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Sickle cell Hb-C disease without crisis"
      },
      "foundationReference": "http://id.who.int/icd/entity/135961609"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hb SC disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/135961609"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hb S Hb C disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/135961609"
    },
    {
      "label": {
        "@language": "en",
        "@value": "sickle-cell HbC disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/135961609"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Sickle cell thalassaemia without crisis"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "sickle-cell thalassaemia"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "sickle-cell beta thalassaemia"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "haemoglobin s/beta thalassaemia"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "thalassaemia with haemoglobin S disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "microdrepanocytosis"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "double heterozygous for Hb S or beta thalassaemia"
      },
      "foundationReference": "http://id.who.int/icd/entity/671487653"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Compound HbS or HbC heterozygotes"
      },
      "foundationReference": "http://id.who.int/icd/entity/1397637756"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Compound HbS, HbD-Punjab or Los Angeles heterozygotes"
      },
      "foundationReference": "http://id.who.int/icd/entity/1601142784"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hb-SD disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1601142784"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Compound HbS or HbE heterozygotes"
      },
      "foundationReference": "http://id.who.int/icd/entity/131785602"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hb SE disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/131785602"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Compound HbS or O-Arab heterozygotes"
      },
      "foundationReference": "http://id.who.int/icd/entity/1110150137"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Double heterozygous sickling disorders with retinopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1533877548"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Glomerular disorders in double heterozygous sickling disorders"
      },
      "foundationReference": "http://id.who.int/icd/entity/371172313"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Gouty arthropathy in double heterozygous sickling disorders"
      },
      "foundationReference": "http://id.who.int/icd/entity/1044782927"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Compound HbS or beta thalassaemia heterozygotes"
      },
      "foundationReference": "http://id.who.int/icd/entity/201007614"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Compound HbS and beta thalassaemia heterozygotes including HbS/delta-beta-thal compounds"
      },
      "foundationReference": "http://id.who.int/icd/entity/201007614"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hereditary persistence of fetal haemoglobin - sickle cell disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1455152722"
    }
  ]
}